Small-volume, easy-to-use, ultrasensitive protein assays
About Us
THE FUTURE OF HEALTHCARE AND WELLNESS
Wellness self-testing and telemedicine-based diagnostics are quickly growing trends. Both increasingly rely on the ability to quantify miniscule amounts of protein biomarkers from at-home collected samples. Platform technologies that enable ultrasensitive detection from small sample volumes and fit into existing workflows for sample collection, processing, and detection, are needed to enable these highly-valued trends.
About Us
THE FUTURE OF HEALTHCARE AND WELLNESS
Wellness self-testing and telemedicine-based diagnostics are quickly growing trends. Both increasingly rely on the ability to quantify miniscule amounts of protein biomarkers from at-home collected samples. Platform technologies that enable ultrasensitive detection from small sample volumes and fit into existing workflows for sample collection, processing, and detection, are needed to enable these highly-valued trends.
Spear Bio Inc. has developed a reagent-based technology for ultrasensitive protein detection. This novel solution offers significant benefits across the healthcare value chain.
CEO
Michael Natan
CEO, Co-founder
Michael brings over 25 years of entrepreneurial activity in the life science space to Spear Bio. He was previously CEO of Ultivue Inc, Oxonica Materials, and Nanoplex Technologies and served as CTO and VP of Business Development at SurroMed. Michael holds a BS in Chemistry from Yale University and a PhD in Biochemistry from MIT.
Our Team
Feng Xuan
CTO, Co-Founder
Feng has spent the last decade researching and inventing new techniques in the field of molecular and immuno-diagnostics. Before joining Spear Bio, he was the Technology Development Fellow at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he invented Spear Bio's core technology. Feng received his B.S. in Chemistry & M.Phil. in Biomedical Engineering from Hunan University and his Ph.D. in Chemical and Biomolecular Engineering from Hong Kong University of Science and Technology.
CTO
Co-Founder
Peng Yin
Co-Founder
Peng is a Professor in the Department of Systems Biology at Harvard Medical School. He also serves as a Core Faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University, where he co-founded Ultivue. Peng obtained his Ph.D. degree in computer science and MS in molecular cancer biology from Duke University, and a BS in biochemistry and molecular biology from Peking University.
Oliver Tassinari
Sr. Director, Commercial Strategy and Business Development
Oliver has spent the last decade leading business development and product management teams developing new markets and launching cutting edge, technology-driven products. Oliver most recently led program and product management teams at Thermo Fisher Scientific. He has a BS in Biological Engineering from Cornell University and an MBA from Carnegie Mellon University.
Commercial Strategy
Careers
Spear Bio will be building out its commercial and technical teams in the coming months to help bring our solutions to market. To that end, we will be looking for top talent with clinical diagnostics industry experience and functional experiences including R&D, Product Development, Business Development, and Product Management.
If you are interested in joining out team, please send your resume to careers@spear.bio.
Check this page regularly as we plan on posting new positions soon!